Jeffrey Rosen
0000-0002-6637-844X
13 papers found
Refreshing results…
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer
Single Cell Analysis Unveils the Role of the Tumor Immune Microenvironment and Notch Signaling in Dormant Minimal Residual Disease
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers
Noncanonical Wnt/Ror2 signaling regulates cell-matrix crosstalk to prompt directional tumor cell invasion and dissemination in breast cancer
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
TIME Is a Great Healer—Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes
Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and niche interactions
New twists on long noncoding RNAs: from mobile elements to motile cancer cells
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis
Correction: Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
Missing publications? Search for publications with a matching author name.